The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Open accessPublished version of a preprint
Abstract
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-γ-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4+ and/or CD8+ epitopes, including six immunodominant regions. Six optimized CD8+ epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8+ T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredIn the citing paper
“By contrast, VAERD has not usually occurred if a TH1 cell-biased CD4+ T cell response is elicited, reflected by increased levels of interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF)44–46,49.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [46]
In the citing paper
“Robust CD4+ and CD8+ T cell memory is induced after COVID-19,22,39, 40, 41 and multiple COVID-19 vaccines elicit CD4+ and CD8+ T cell responses.26,42, 43, 44, 45”
From Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals (2021) · cites this paper as [40]
In the citing paper
“It should be noted that all plasma and sera tested completely inhibited entry at the lowest dilution tested and that T cell responses will contribute to control of SARS-CoV-2 infection, particularly in re-infected convalescent patients (Grifoni et al., 2020; Peng et al., 2020).”
From SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) · cites this paper as Peng et al., 2020
In the citing paper
“T cell responses are detected after almost all SARS-CoV-2 infections (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Peng et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“In SARS-CoV-2 infections, the presence of virus-specific CD8+ T cells has been associated with better COVID-19 outcomes (Rydyznski Moderbacher et al., 2020; Peng et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“Current evidence suggests an early, robust, and diverse T cell response directed against SARS-CoV-2 correlates with milder COVID-19 outcomes126,131,132”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“Severe COVID-19 has been associated with lower TCR diversity against SARS-CoV-2 epitopes131,132.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“For CD8+ T cells, there are reports of diminished CD8+ cytotoxicity and cytokine production in severe cases126,132, while others report the opposite141, and still others find no differences142.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Self-citationFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citation
Research works printed but not linked: 1
- Fehr, A. R. & Perlman, S. in Coronaviruses. Methods in Molecular Biology Vol. 1282 (eds Maier H., Bickerton E., Britton P.) 1–23 (Humana Press, 2015).
Cited by
Sorted by citations
Items 801–900 of 1,000
MHC class I links with severe pathogenicity in C57BL/6N mice infected with SARS-CoV-2/BMA8
Qin, T., Shen, B., Li, E., Jin, S., Luo, R., Zhang, Y., Qi, J., Deng, X., Shi, Z., Wang, T., et al. (2023) · Virology Journal · doi:10.1186/s12985-023-02031-0 · Cited by 7
Self-citationClinical and Immunological Impacts of Latent Toxoplasmosis on COVID-19 Patients
Habib, S., Hamza, E., El‐Gamal, R., Nosser, N. A., Aboukamar, W. A., Abdelsalam, S. A., Sobh, A., Elegezy, M., Elbayoumy, M. K., Eldars, W., et al. (2023) · Cureus · doi:10.7759/cureus.45989 · Cited by 5
Peng, X., Zhu, X., Liu, X., Huang, Y., & Zhu, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30394 · Cited by 6
Pedroso, R., Torres, L., Ventura, L. H. D. A., Camatta, G. C., Mota, C., Mendes, A. C., Ribeiro, F., Guimarães, H. C., Barbuto, R. C., Caixeta, F., et al. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae180 · Cited by 9
Pinto, P. B. A., Timis, J., Chuensirikulchai, K., Li, Q. H., Lu, H.-H., Maule, E., Nguyen, M. N., Alves, R. P. D. S., Verma, S. K., Ana‐Sosa‐Batiz, F., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-01043-3 · Cited by 8
Bozkus, C. C., Brown, M., Velazquez, L. G., Thomas, M., Wilson, E. A., O’Donnell, T. J., Kaminska, A., Ruchnewitz, D., Geertz, D., Bykov, Y., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113044 · Cited by 9
Jin, X., Liu, X. K., Zhou, Z., Ding, Y., Wu, Y., Qiu, J., & Shen, C. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03096-y · Cited by 6
The immunologic response to severe acute respiratory syndrome coronavirus 2
Le, N. K., Kaman, K., Martin, H. C., Mullur, J., Stenehjem, K. K., Coomar, L. A., Bahar, B., Dutta, M., Izurieta, R., & Brooks, J. P. (2021) · Allergy and Asthma Proceedings · doi:10.2500/aap.2021.42.210077 · Cited by 6
Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients
Cheng, M., Liu, H., Chao Hui, Z. H. O. U., Li, R.-T., Zheng, J., Qin, Y., Yang, N., Zhang, Y., Huang, J., Zhu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.911859 · Cited by 6
Self-citationProteomics research of SARS-CoV-2 and COVID-19 disease
Zhang, N., Wang, S., & Wong, C. C. L. (2022) · Medical Review · doi:10.1515/mr-2022-0016 · Cited by 7
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization
Bertoletti, A., Bert, N. L., & Tan, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810679 · Cited by 6
Wang, R., Zhang, M., Zhang, L., Liu, M., Shan, C., An, J., & Xie, Z. (2022) · Journal of Tropical Medicine · doi:10.1155/2022/8379286 · Cited by 6
Hong, L., Nian, X., Wu, J., Liu, D., Feng, L. Z., Lu, J., Peng, Y., Zhou, Z., Deng, T., Liu, J., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00496-x · Cited by 6
Self-citationAl‐Akioui‐Sanz, K., Pascual-Miguel, B., Díaz‐Almirón, M., Mestre‐Durán, C., Navarro‐Zapata, A., Villa, L. C., Martín-Cortázar, C., Vicario, J. L., Moreno, M. Á., Balas, A., et al. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.12.001 · Cited by 5
Schnizer, C., Andreas, N., Vivas, W., Kamradt, T., Baier, M., Kiehntopf, M., Glöckner, S., Scherag, A., Löffler, B., Kolanos, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1095129 · Cited by 6
Vaccination Provides Superior in vivo Recall Capacity of SARS-CoV-2 Specific Memory CD8 T Cells
Kavazović, I., Dimitropoulos, C., Gašparini, D., Filipović, M. R., Barković, I., Köster, J., Lemmermann, N. A. W., Babić, M., Cekinović, Đ., & Wensveen, F. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2023.112395 · Cited by 6
Nam, H., Koh, J., Jung, J. H., Jeong, H., Jeong, H. W., Cheon, S., Park, S., Ys, K., & Shin, E. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200290 · Cited by 6
Identification of natural killer markers associated with fatal outcome in COVID-19 patients
Tarantino, N., Litvinova, E., Samri, A., Soulié, C., Morin, V., Rousseau, A., Dorgham, K., Parizot, C., Bonduelle, O., Beurton, A., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1165756 · Cited by 7
Ratishvili, T., Quach, H. Q., Haralambieva, I. H., Suryawanshi, Y. R., Ovsyannikova, I. G., Kennedy, R. B., & Poland, G. A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.12.024 · Cited by 6
Fernández‐Soto, D., Bueno, P., Garaigorta, U., Gastaminza, P., Bueno, J. L., Duarte, R. F., Jara‐Acevedo, R., Valés‐Gómez, M., & Reyburn, H. T. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae017 · Cited by 6
The coevolution of Covid-19 and host immunity
Haque, A., & Pant, A. B. (2024) · Exploration of Medicine · doi:10.37349/emed.2024.00214 · Cited by 8
Hare, J., Morrison, D., & Nielsen, M. (2021) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2021.622992 · Cited by 6
Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
Zhu, A., Chen, Z., Wang, Y., Zeng, Q., Sun, J., Zhuang, Z., Li, F., Zhao, J., Zhao, J., & Zhong, N. (2021) · Fundamental Research · doi:10.1016/j.fmre.2021.03.001 · Cited by 7
Harbour, J. C., Lyski, Z. L., Schell, J. B., Thomas, A., Messer, W. B., Slifka, M. K., & Nolz, J. C. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100054 · Cited by 6
A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
Yeo, J. G., Leong, J. Y., Tay, S. H., Nadua, K. D., Anderson, D. E., Lim, A. J. M., Ng, X. W., Poh, S. L., Guo, D., Yaung, K. N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674279 · Cited by 7
Sivapalan, R., Liu, J., Chakraborty, K., Arthofer, E., Choudhry, M. S., Barie, P. S., Barouch, D. H., & Henley, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-94654-y · Cited by 6
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
Lim, H. Y., Arip, M., Yahaya, A. A. A.-F. B., Jazayeri, S. D., Poppema, S., & Poh, C. L. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/5024 · Cited by 6
Vallejo, A., Martín-Hondarza, A., Gómez, S., Velasco, H., Vizcarra, P., Häemmerle, J., & Casado, J. L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.812729 · Cited by 6
Olea, B., Albert, E., Giménez, E., Torres, I., Amat, P., Remigia, M. J., Alberola, J., Carbonell, N., Ferreres, J., Blasco, M. L., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-18659-x · Cited by 6
Díaz-Dinamarca, D. A., Díaz, P., Barra, G. N., Puentes, R., Arata, L., Grossolli, J., Riveros-Rodriguez, B., Ardiles, L., Santelises, J., Vásquez-Sáez, V., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1229045 · Cited by 7
Todorov, G. I., & Uversky, V. N. (2020) · Biomolecules · doi:10.3390/biom10101438 · Cited by 6
Deciphering the ins and outs of SARS-CoV-2-specific T cells
Perez‐Potti, A., Lange, J., & Buggert, M. (2020) · Nature Immunology · doi:10.1038/s41590-020-00838-5 · Cited by 7
Pushpakumara, P. D., Madusanka, D., Dhanasekara, S., Jeewandara, C., Ogg, G. S., & Malavige, G. N. (2021) · Viruses · doi:10.3390/v13060972 · Cited by 5
Self-citationSergeeva, M. V., Vasilev, K., Romanovskaya-Romanko, E., Yolshin, N. D., Pulkina, A., Shamakova, D., Shurygina, A.-P. S., Muzhikyan, A., Lioznov, D. A., & Stukova, M. (2024) · Vaccines · doi:10.3390/vaccines13010015 · Cited by 5
Patel, R. S., Duque, D., Bavananthasivam, J., Hewitt, M., Sandhu, J. K., Kumar, R. K., Tran, A., & Agrawal, B. (2025) · ImmunoHorizons · doi:10.1093/immhor/vlae011 · Cited by 5
Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication
le Chevalier, F., Authié, P., Chardenoux, S., Bourgine, M., Vesin, B., Cussigh, D., Sassier, Y., Fert, I., Noirat, A., Nemirov, K., et al. (2023) · Microbes and infection · doi:10.1016/j.micinf.2023.105142 · Cited by 5
Huang, Z., Sun, Q., Shi, H., Yang, S., Li, Y., Ma, Y., Yang, F., Shi, Z., Yang, Y., Zhang, Y., et al. (2023) · ChemPhysMater · doi:10.1016/j.chphma.2023.03.005 · Cited by 5
Self-citationMacchia, I., Sorsa, V. L., Ciervo, A., Ruspantini, I., Negri, D. R. M., Borghi, M., Angelis, M. L. D., Luciani, F., Martina, A., Taglieri, S., et al. (2024) · Biomolecules · doi:10.3390/biom14101217 · Cited by 6
Deng, S., Xu, Z., Hu, J., Yang, Y., Zhu, F., Liu, Z., Zhang, H., Wu, S., & Jin, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1468456 · Cited by 5
Li, J., Li, P., Yuan, S., Xue, J.-C., Zhang, Q., & Gao, B. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114118 · Cited by 5
Singh, V. K., Chaurasia, H., Mishra, R., Srivastava, R., Yadav, A. K., Dwivedi, J., Singh, P., & Singh, R. K. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220729093340 · Cited by 5
Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
Wei, X., Rong, N., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993754 · Cited by 6
Zhang, Y., Chen, Y., Cao, J.-D., Liu, H., & Li, Z. (2022) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2022.3214076 · Cited by 4
Self-citationWang, S., Li, J., Wang, S., Ye, Y., Li, M., Liu, Y., Chen, B., Lai, Y., Li, L., Zhuang, L., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1171 · Cited by 5
Li, Z., Xiang, T., Liang, B., Liu, J., Deng, H., Yang, X., Wang, H., Feng, X., Zelinskyy, G., Trilling, M., et al. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.06.011 · Cited by 5
Self-citationImmunity Agent-Based Model (IABM) for epidemiological systems
Gonzaga, M. N., de Oliveira, M. M., & Atman, A. P. F. (2023) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2023.114108 · Cited by 5
Yang, M. X., Meng, Y., Hao, W., Zhang, J., Liu, J., Wu, L., Lin, B., Liu, Y., Zhang, Y., Yu, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111829 · Cited by 5
Self-citationImmune Responses in Discharged COVID-19 Patients With and Without Long COVID Symptoms
Wang, Y., Guo, L., Cui, D., Zhang, H., Zhang, Q., Ren, X., Wang, G., Zhang, X., Huang, T., Chen, L., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae137 · Cited by 5
Alosaimi, B., Awadalla, M., Alturaiki, W., Zhao, C., Zhang, Z., Zhu, A., Rebh, F. Z., Alshukairi, A. N., Zhao, J., & Alkadi, H. S. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70071 · Cited by 5
COVID-19 and immunity: quo vadis?
Miyasaka, M. (2021) · International Immunology · doi:10.1093/intimm/dxab008 · Cited by 5
The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
Tosta, E. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00014 · Cited by 5
Luo, L., Chen, Q., Han, X., Shen, M., Hu, C., Chen, S., Zhang, J., Wang, Y., Li, T., Huang, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696662 · Cited by 5
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection
Guihot, A., Plu, I., Soulié, C., Rousseau, A., Nakid-Cordero, C., Dorgham, K., Parizot, C., Litvinova, E., Mayaux, J., Malet, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844727 · Cited by 5
Takagi, A., & Matsui, M. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01659-21 · Cited by 5
Thümmler, L., Konik, M., Lindemann, M., Fisenkci, N., Koldehoff, M., Gäckler, A., Horn, P. A., Theodoropoulos, F., Taube, C., Zettler, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.980698 · Cited by 6
Ramos, L., Hernández-Porto, M., Palau, M. C., Alonso-Abreu, I., Reygosa, C., & Hernández‐Guerra, M. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac228 · Cited by 5
Solimando, A. G., Bittrich, M., Shahini, E., Albanese, F., Fritz, G., & Krebs, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108746 · Cited by 5
Postovskaya, A., Vujkovic, A., de Block, T., van Petersen, L., Frankenhuijsen, M. V., Brosius, I., Bottieau, E., Dijck, C. V., Theunissen, C., van Ierssel, S. H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130876 · Cited by 6
Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells
Lie-Andersen, O., Hübbe, M. L., Subramaniam, K. S., Steen-Jensen, D. B., Bergmann, A. C., Justesen, D. L., Holmström, M. O., Turtle, L. C. W., Justesen, S. F. L., Lança, T., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151659 · Cited by 5
Self-citationCharacterizing Distinct Profiles of Immune and Inflammatory Response with Age to Omicron Infection
Zhang, L., Wang, Z., Lyu, F., Liu, C., Li, C., Liu, W., Ma, X., Zhou, J., Qian, X., Qian, Z., et al. (2022) · Frontiers in Immunology · doi:10.2139/ssrn.4272777 · Cited by 5
Self-citationLi, R., Chang, Z., Liu, H., Wang, Y., Li, M., Chen, Y., Lü, F., Wang, S., Sun, X., Liu, S. J., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02293-y · Cited by 6
Self-citationZhang, Y., Yang, Z., Tang, M., Li, H., Tang, T., Li, G., Zhong, Y., Zhang, X., Wang, X., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.752622 · Cited by 5
Self-citationBrentville, V. A., Vankemmelbeke, M., Metheringham, R. L., Symonds, P., Cook, K., Urbanowicz, R. A., Tsoleridis, T., Coleman, C., Chang, K.-C., Skinner, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.18.448932 · Cited by 5
Goliwas, K. F., Wood, A. M., Simmons, C. S., Khan, R., Khan, S. A., Wang, Y., Berry, J. L., Athar, M., Mobley, J. A., Kim, Y., et al. (2021) · medRxiv · doi:10.1101/2021.09.02.21263042 · Cited by 6
Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron (B.1.1.529)Preprint
Gao, Y., Cai, C., Grifoni, A., Müller, T. R., Niessl, J., Olofsson, A., Humbert, M., Hansson, L., Österborg, A., Bergman, P., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1217466/v1 · Cited by 5
Lin, J., Law, R., Korosec, C. S., Zhou, C. Y., Koh, W. H., Ghaemi, M. S., Samaan, P., Ooi, H. K., Yue, F., Gingras, A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.18.476864 · Cited by 5
Ford, E. S., Mayer-Blackwell, K., Jing, L., Sholukh, A. M., Germain, R. S., Bossard, E. L., Xie, H. J., Pulliam, T. H., Jani, S., Selke, S., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2146712/v1 · Cited by 6
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccinePreprint
Grandi, A., Tomasi, M., Ullah, I., Bertelli, C., Vanzo, T., Accordini, S., Gagliardi, A., Zanella, I., Benedet, M., Corbellari, R., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2788726/v1 · Cited by 5
Halvorson, T., Boucher, G., Yokosawa, D., Huang, J., García, R., Sanderink, L., Chen, L., Liu, L., Fajardo-Despaigne, J. E., Halvorson, J., et al. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101458 · Cited by 5
Yuan, P., Chen, G., Li, Y., Liu, X., Saravanakumar, S., Zhao, J., Ji, Q., Wang, H., Lin, Y., Elbahnasawy, M. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66322-6 · Cited by 5
Viana, K. F., Zarpelon, L. F. B., Leandro, A., Terêncio, M. L., Lopes, R. D., Martins, C. A., Silva, I., Sibim, A. C., Marques, F., SILVA, R. D., et al. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001684 · Cited by 4
Saksena, N. K., Bonam, S. R., & Saksena, M. M. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00007 · Cited by 4
Multicomponent vaccines to fight SARS-CoV-2 variants of concern
Cassone, A., & Cauda, R. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.10.069 · Cited by 4
Naïve T cells may be key to the low mortality of children with COVID‐19
Zhang, W., Zhou, Y., & Kang, Y. (2022) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12454 · Cited by 4
Time-dependent contraction of the SARS-CoV-2–specific T-cell responses in convalescent individuals
Fernandes, E. R., Apostólico, J. D. S., Jacintho, L. C., Marin, M. L. C., Júnior, R. C. V. D. S., Rodrigues, H., Santos, K. S., Coelho, V. P. C. V., Boscardin, S. B., Kalil, J. E., et al. (2022) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2022.05.002 · Cited by 4
Jian, X., Zhang, Y. L., Zhao, J., Zhao, Z., Lu, M., & Xie, L. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.01.038 · Cited by 4
Self-citationImproved Performance of the QuantiFERON-SARS-CoV-2 Assay with the Extended Set
Mahammed, L. L., Bensaid, K., Ait-Seddik, S., Larinouna, A., Brahimi, G., Belkaid, R., Hamzaoui, O., Rouaki, S. M., Idder, C., Allam, I., et al. (2023) · Viruses · doi:10.3390/v15051179 · Cited by 4
Ssali, I., Mugaba, S., Watelo, A. K., Bemanzi, J., Katende, J. S., Oluka, G. K., Ankunda, V., Baine, C., Kato, L., Onyachi, N., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.09.001 · Cited by 4
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery
Ali, M., Longet, S., Neale, I., Rongkard, P., Chowdhury, F. U. H., Hill, J. W., Brown, A., Laidlaw, S. M., Tipton, T., Hoque, A. M., et al. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae030 · Cited by 4
Self-citationMuraoka, D., Meng, L.-M., Muto, O., Nakatsukasa, T., Deng, S.-T., Takashima, C., Yamaguchi, R., Sawada, S.-I., Hayakawa, H., Nguyen, T. T. N., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00961-6 · Cited by 4
A hitchhiker's guide through the COVID-19 galaxy
Felsenstein, S., & Reiff, A. O. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108849 · Cited by 4
Immunological Biomarkers in Blood to Monitor the Course and Therapeutic Outcomes of COVID-19
Wieland, E. (2021) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000945 · Cited by 4
Immune dynamics of SARS-CoV-2 virus evolution
Kamat, M., Kurlawala, V., Ghosh, G., & Vaishnav, R. (2022) · International Journal of Molecular and Immuno Oncology · doi:10.25259/ijmio_26_2021 · Cited by 4
Rives, B. T., Rosales, Y. Z., Valdés, M. M., Balbuena, H. R., Téllez, G. M., Pérez, J. R., Padrón, L. C. M., Pelier, C. V. R., Lugo, F. S., Valdés-Zayas, A., et al. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152216 · Cited by 5
Sсherbak, S. G., Vologzhanin, D. A., Голота, А. С., Kamilova, Т. A., & Макаренко, С. В. (2022) · Journal of clinical practice · doi:10.17816/clinpract106239 · Cited by 5
Viral immunogenic footprints conferring T cell cross-protection to SARS-CoV-2 and its variants
Antonio, E. C., Meireles, M. R., Bragatte, M. A. D. S., & Vieira, G. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931372 · Cited by 4
Odendahl, M., Endler, I., Haubold, B., Rodionov, R. N., Bornstein, S. R., & Tonn, T. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.09.007 · Cited by 4
Yang, K., Liu, J., Gong, Y., Li, Y., & Liu, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1052850 · Cited by 4
Sorcini, D., Falco, F. D., Gargaro, M., Bozza, S., Guarente, V., Cardinali, V., Stella, A., Adamo, F. M., Barcelos, E. C. S., Rompietti, C., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18602 · Cited by 4
Assesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents
Blyakher, M. S., Fedorova, I. M., Tulskaya, E. A., Всеволодович, К. И., Игоревна, К. С., Керимовна, Р. З., Евгеньевич, О. Е., Вячеславовна, С. С., & Novikova, L. I. (2022) · Problems of Virology · doi:10.36233/0507-4088-151 · Cited by 4
Germanó, M. J., Giai, C., Cargnelutti, D. E., Colombo, M. I., Blanco, S., Konigheim, B. S., Spinsanti, L., Aguilar, J., Gallego, S. V., Valdez, H., et al. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28584 · Cited by 5
Ternette, N., Adamopoulou, E., & Purcell, A. W. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101780 · Cited by 4
Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
Duette, G., Lee, E., Gomes, G. M. C., Tungatt, K., Doyle, C. M., Stylianou, V. V., Lee, A., Maddocks, S., Taylor, J., Khanna, R., et al. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2300034 · Cited by 4
Wen, Y., Chen, R., Yang, J., Yu, E., Liu, W., Liao, Y., Wen, Y., Wu, R. J., Zhao, Q., Du, S., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126327 · Cited by 4
Taylor, J. V., Callery, E. L., & Rowbottom, A. W. (2023) · Journal of Immunological Methods · doi:10.1016/j.jim.2023.113556 · Cited by 4
Kam, N., Lau, C. Y., Che, C., & Lee, V. H.-F. (2023) · Cancers · doi:10.3390/cancers15194850 · Cited by 5
Hall, V. G., Nguyen, T. H. O., Allen, L. F., Rowntree, L. C., Kedzierski, Ł., Chua, B. Y. L., Lim, C., Saunders, N. R., Klimevski, E., Tennakoon, S., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad550 · Cited by 4
Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine
Rabdano, S. O., Ruzanova, E., Makarov, D., Vertyachikh, A. E., Teplykh, V. A., Rudakov, G. O., Pletyukhina, I. V., Saveliev, N., Анатольевич, З. К., Alpenidze, D., et al. (2024) · Vaccines · doi:10.3390/vaccines12010100 · Cited by 4
A Comprehensive Study of Cellular and Humoral Immunity in Dogs Naturally Exposed to SARS‐CoV‐2
Tomeo-Martín, B. D., Delgado-Bonet, P., Cejalvo, T., Herranz, S., & Perisé-Barrios, A. J. (2024) · Transboundary and Emerging Diseases · doi:10.1155/2024/9970311 · Cited by 4
Metadata
- Authors
- Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., López-Camacho, C., Slon-Campos, J., Zhao, Y., Stuart, D. I., Paesen, G. C., Grimes, J. M., Antson, A. A., Bayfield, O. W., Hawkins, D. E. D. P., Ker, D.-S., Wang, B., Turtle, L., Subramaniam, K., Thomson, P., Zhang, P., Dold, C., Ratcliff, J., Simmonds, P., de Silva, T., Sopp, P., Wellington, D., Rajapaksa, U., Chen, Y.-L., Salio, M., Napolitani, G., Paes, W., Borrow, P., Kessler, B. M., Fry, J. W., Schwabe, N. F., Semple, M. G., Baillie, J. K., Moore, S. C., Openshaw, P. J. M., Ansari, M. A., Dunachie, S., Barnes, E., Frater, J., Kerr, G., Goulder, P., Lockett, T., Levin, R., Zhang, Y., Jing, R., Ho, L.-P., Oxford Immunology Network Covid-19 Response T cell Consortium, Barnes, E., Dong, D., Dong, T., Dunachie, S., Frater, J., Goulder, P., Kerr, G., Klenerman, P., Liu, G., McMichael, A., Napolitani, G., Ogg, G., Peng, Y., Salio, M., Yao, X., Yin, Z., ISARIC4C Investigators, Kenneth Baillie, J., Klenerman, P., Mentzer, A. J., Moore, S. C., Openshaw, P. J. M., Semple, M. G., Stuart, D. I., Turtle, L., Cornall, R. J., Conlon, C. P., Klenerman, P., Screaton, G. R., Mongkolsapaya, J., McMichael, A., Knight, J. C., Ogg, G., & Dong, T.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- University of York (GB)
- University of Liverpool (GB)
- University of Sheffield (GB)
- ProImmune (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- Worthing Hospital (GB)
- Capital Medical University (CN)
- University of Edinburgh (GB)
- Siriraj Hospital (TH)
- ORCID
- Dejnirattisai, Wanwisa
- Supasa, Piyada
- Liu, Chang
- López-Camacho, César
- Slon-Campos, Jose
- Zhao, Yuguang
- Paesen, Guido C.
- Grimes, Jonathan M.
- Antson, Alfred A.
- Bayfield, Oliver W.
- Hawkins, Dorothy E. D. P.
- Ker, De-Sheng
- Wang, Beibei
- Subramaniam, Krishanthi
- Thomson, Paul
- Zhang, Ping
- Dold, Christina
- Ratcliff, Jeremy
- Simmonds, Peter
- de Silva, Thushan
- Wellington, Dannielle
- Rajapaksa, Ushani
- Chen, Yi-Ling
- Paes, Wayne
- Borrow, Persephone
- Kessler, Benedikt M.
- Fry, Jeremy W.
- Ansari, M. Azim
- Zhang, Yonghong
- Ho, Ling-Pei
- Cornall, Richard J.
- Screaton, Gavin R.
- Mongkolsapaya, Juthathip
- Knight, Julian C.
- Venue
- Nature Immunology
- Published
- 2020-09-04
- Volume
- 21
- Issue
- 11
- Pages
- 1336-1345
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7611020
- OpenAlex
- W3082438395
- Cited by
- 1,179
- References
- 42
- Citations by year
- 2026: 41 · 2025: 68 · 2024: 118 · 2023: 171 · 2022: 291 · 2021: 398 · 2020: 91
- FWCI
- 30.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Immunology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (acceptedVersion)
- PubMed Central (submittedVersion)
- Funders
- RCUK | Medical Research Council (MC_PC_19059)
- Chinese Academy of Medical Sciences (2018-I2M-2-002)
- China Scholarship Council
- Wellcome Trust (205228/Z/16/Z, 110058/Z/15/Z, 215091/Z/18/Z, 095541/A/11/Z, award 206377 to AAA)
- DH | NIHR | Health Services Research Programme (NIHR200907, CO-CIN-01)
- University of Liverpool
- University of Oxford
- University of Edinburgh
- DH | National Institute for Health Research (NIHR200927 /WHRG_P82523, NIHR201385 / WHRR P84026, NIHR200907)
- Imperial College London (IS-BRC-1215-20013)
- Worthing Hospital
- Oxford University Hospitals NHS Trust
- National Institutes of Health, National Key R&D Program of China
- University of York
- ProImmune Ltd
- Bill and Melinda Gates Foundation (MC_PC_19059)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell memory, CD4+ T cells, CD8+ T cells, epitope mapping, immunodominant epitopes, spike protein, disease severity, convalescent patients, central memory T cells, effector memory T cells, antiviral immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
